手机咨询更便捷
扫码立即和HR沟通
Responsibility主要职责
· Execute scientifically robust and efficient clinical
pharmacology strategies for NME and/or development candidates, working together
with senior members.
· Contribute to overall compound development via application of
quantitative methods to integrate knowledge of PK, PD, patient
characteristics, disease states, and drug-drug interactions to optimize dose
selection, dosage regimens and study designs throughout drug development.
· Provide the clinical pharmacokinetics and pharmacodynamics
expertise and support required for Investigator Brochures, Clinical Trials
Applications, Marketing Applications, regulatory meetings, and responses to
regulatory questions.
· Work effectively in matrix environment,
managing ClinPharm deliverables in accordance with timelines and overall
project goals.
Requirement任职要求
· Willingness to Acknowledge Areas for Growth: Understands need
for growth and is receptive to constructive feedback.
· Detail-Oriented: Follows precise procedures and demonstrates
thoroughness in performing job tasks and assignments.
· Communication Skills: The ability to convey both written and
verbal information effectively and efficiently.
· Fluent in spoken English and good in written
迪哲医药(股票代码:688192)是一家创新型生物医药企业,专注于恶性肿瘤、免疫性疾病领域创新疗法的研究、开发和商业化。公司坚持源头创新的研发理念,以推出全球首创药物(First-in-class)和具有突破性潜力的治疗方法为目标,旨在填补全球未被满足的临床需求。基于行业领先的转化科学和新药分子设计与筛选技术平台,公司已建立了五款具备全球竞争力的产品管线,两大领先产品处于全球关键性临床试验阶段,其中一款已获批上市。
Dizal Pharmaceutical Co., Ltd (Ticker: 688192 ) is a commercial stage biopharmaceutical company. At Dizal we aspire to discover and develop differentiated therapeutics for the treatment of cancer and immunological diseases. Building on our extensive expertise in translational science and molecular design, we have established an internationally competitive portfolio of five clinical-stage assets with two leading assets in global pivotal studies and one already approved.